A great read on the ongoing work in this space.
https://www.cancertherapyadvisor.com/general-oncology/cancer-vaccine-research-checkpoint-inhibitors-use/article/831732/
From the company's announcement dated 27/07/18 below....
https://hotcopper.com.au/threads/ann-successful-in-vivo-results-peptide-vaccine-t-cell-expansion.4325318/
"The peptide vaccine program continues to progress in the context of multiple different antigens (cargoes) and disease indications towards its ultimate read-out of complementarity to existing therapies in each of these indications to demonstrate improved treatment efficacy."
"complementarity to existing therapies"
Tony
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.005(0.42%) |
Mkt cap ! $702.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.23 | $1.20 | $412.4K | 342.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 512674 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 62126 | 4 |
View Market Depth
| Last trade - 11.12am 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |